Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1293 of 5804
-
New study tests Mesh-Free option for bladder leak surgery
Symptom relief Recruiting nowThis prospective clinical study aims to compare the short-term effectiveness, safety, and patient-reported outcomes of two surgical techniques used for the treatment of female stress urinary incontinence (SUI): Pubo-Urethral Ligament Plication (PLP), a mesh-free native tissue rep…
Phase: NA • Sponsor: Mehmet Incebıyik • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Injectable hydrogel could ease back pain without surgery
Disease control Recruiting nowA multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.
Phase: NA • Sponsor: ReGelTec, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New implant could replace glaucoma drops after cataract surgery
Disease control Recruiting nowThis trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Phase: PHASE4 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
App-based program aims to slow kidney disease with lifestyle support
Disease control CompletedThe goal of this clinical trial is to find out if the Digital Dyadic Empowerment Program (DDEP) can help people with chronic kidney disease (CKD) and their care partners make healthy lifestyle changes. The main questions this study will answer are: * Does DDEP help protect kidne…
Phase: NA • Sponsor: National Cheng Kung University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Nerve transfer surgery aims to restore smiles in cancer patients
Symptom relief Recruiting nowThe goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New drug IMC-001 targets Hard-to-Treat cancers in small trial
Disease control Recruiting nowThe goal of this clinical trial is to determine the efficacy of IMC-001 in metastatic or locally advanced TMB-H solid tumor patients.
Phase: PHASE2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New implant aims to make dialysis easier for kidney patients
Disease control Recruiting nowVasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side…
Phase: NA • Sponsor: Laminate Medical Technologies • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can fat cell therapy help Normal-Weight diabetics?
Disease control Recruiting nowThis study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), and normal-weight controls without diabetes (NWC). The study will assess whether a…
Phase: PHASE4 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a blood pressure cuff save brain function after heart stoppage?
Disease control Recruiting nowPatients admitted to intensive care unit (ICU) following an out-of-hospital cardiac arrest (OHCA) have a high morbidity and mortality rate, primarily due to ischemia-reperfusion (I/R) syndrome leading to anoxic-ischemic brain injury. Despite current recommended advanced life supp…
Phase: NA • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Immune clues in schizophrenia: could inflammation subtypes guide treatment?
Knowledge-focused Recruiting nowSchizophrenia is a severe mental illness that seriously affects the health and functioning of patients. Previous studies have found immunoinflammatory abnormalities in the blood, cerebrospinal fluid, central nervous system, and neuroimaging of people with schizophrenia, along wit…
Sponsor: Central South University • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New shot could help when arthritis drugs fail
Disease control OngoingThis Phase 2b, multicenter, double-blind, placebo-controlled, randomized withdrawal study is designed to assess the efficacy and safety of IMVT-1402 in adult participants with active, difficult-to-treat, anti-citrullinated protein autoantibody (ACPA) positive rheumatoid arthritis…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for teens with type 2 diabetes: Higher-Dose dulaglutide under study
Disease control Recruiting nowThe main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Young poop pills could help seniors fight frailty and brain decline
Disease control OngoingSarcopenia, characterized by the progressive loss of muscle mass and strength in older adults, is a key factor in health deterioration. It affects 15% of people between 65 and 80 years old and over 50% of those over 80, compromising autonomy and increasing the risk of diseases. S…
Phase: PHASE1 • Sponsor: Gonzalo Jorquera, PhD • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take on advanced liver cancer in first human trial
Disease control Recruiting nowA phase I clinical study of the safety and tolerability, efficacy of CNCT19 CAR T-cell therapy in patients with advanced hepatocellular carcinoma hepatocellular carcinoma.
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
App aims to slash HIV rates in young gay and bisexual men
Prevention Recruiting nowThis study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29…
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New chickenpox vaccine shows promise in toddler trial
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this study is to assess the consistency of immune response to three different lots of GSK's investigational varicella vaccine (VNS Vaccine), and to compare the safety and immune response of VNS vaccine to an already approved varicella vaccine (VV) known as Varivax.…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat cancers: first human trial of BGB-58067 begins
Disease control Recruiting nowThis is an open-label, multicenter, first-in-human dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of BGB-58067 alone, in combination with BG-89894 (discontinued), and in combina…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Berry extract trial aims to stave off cognitive decline in At-Risk seniors
Disease control Recruiting nowGlobally, populations are aging thereby increasing healthcare burden, overall cognitive impairment, and dementia including Alzheimers diseases (AD). The lack of effective treatments makes it essential to develop new strategies for healthy cognitive aging, including interventions …
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Smartphone app listens for heart failure danger signs
Knowledge-focused OngoingPRE-DETECT-HF is a prospective, single-arm observational study evaluating a voice-based machine learning algorithm for early detection of heart failure decompensation. 123 patients hospitalized for acute decompensated or de-novo heart failure will be enrolled across three sites i…
Sponsor: Noah Labs • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New hope for hemophilia a: experimental clotting factor shows promise in chinese trial
Disease control OngoingFor bridging the available global clinical data of rVIII-SingleChain, with the Chinese population, the aim of this study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after an initial and repeat dose and to assess efficacy and safety during 2 to 3 time…
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC